CIENCIASMEDICASNEWS: SARS-CoV-2 Specific and Neutralizing Antibodies

martes, 30 de junio de 2020

SARS-CoV-2 Specific and Neutralizing Antibodies

	Immunology
	The latest immunology news from News Medical

SARS-CoV-2 Specific and Neutralizing Antibodies

Sino Biological has developed a panel of antibodies against SARS-CoV-2. These antibodies can be used to detect and/or neutralize the virus in a variety of assays including ELISA, western blot, Immunofluorescent staining, Immunohistochemistry, SPR (Biacore and Octet), psuedovirus infection, and potentially in vivo animal studies.

Find Out More

High-Speed, High-Throughput Cell Counters for Concentration and Viability

A high-throughput automated cell counting system, the Cellaca MX is able to image, analyze, and report cell concentration and viability for 24 samples in 48 seconds, by using bright field (trypan blue), and in 2.5 minutes by using several fluorescent imaging channels.

[Webinar] Ultrasensitive SIMOA™ Immunoassays Impacting COVID-19, Infectious Diseases, and Immunology

This Quanterix SIMOA™ ultra-sensitive immunoassay system offers the ability to detect and quantitate key cytokines involved early in the disease progression, providing insight like “a radar system” into “prediction” of subsequent immune complications. Hear about the efforts around frontline immunological and serologic assessments of COVID-19 patients and examples of approaches for auto-immune, vaccine, and infectious disease research.

Learn More

	What is Immune Checkpoint Therapy? Immune checkpoints are proteins or protein complexes that lie at strategic points in cellular pathways involved in the regulation of the immune system.

	Hepatitis C virus co-opts an immune protein to evade antiviral defenses By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defense system that could be used to treat many virus infections, according to new research published today in eLife.

	'Relaxed' T Cells are Critical To Immune Response Your T cells manage what seems like an improbable task: quickly finding a few invaders among the many imposters in your body to trigger its immune response.

	Manipulating immune cells could be a viable strategy for treating cancer Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell.